Skip to content

Clinical trials

Completed Phase 2 Myocardial Infarction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 2 Status: Completed Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20035
20044
20053
20065
20074
20085
20096
20102
20114
20124
20132
20141
20152
20162
20172
20181
20191
20202
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Bayer2
Hospices Civils de Lyon2
Mesoblast, Inc.2
Oslo University Hospital2
Barts & The London NHS Trust1
Biopure Corporation1
Brigham and Women's Hospital1
Cardior Pharmaceuticals GmbH1
Careggi Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction62
Coronary Artery Disease8
Myocardial Ischemia8
Acute Coronary Syndrome7
Coronary Disease7
Heart Diseases7
Angina, Unstable6
Cardiovascular Diseases6
ST Elevation Myocardial Infarction6
Heart Failure4

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.